Date stringdate 2012-01-01 00:00:00 2023-12-31 00:00:00 | Stock_symbol stringlengths 1 5 | Article_title stringlengths 1 255 | Article stringlengths 1 342k |
|---|---|---|---|
2021-12-14 00:00:00+00:00 | ABBV | 2 Warren Buffett Dividend Stocks to Buy Right Now | Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) CEO Warren Buffett is perhaps the best-known value investor of all time. Buffett's concept of value centers around the idea of a deep competitive moat, a sustainable business model, and strong free cash flows.
As a result, most of Berkshire's top holdings over the past sev... |
2021-12-14 00:00:00+00:00 | ABBV | Why Soliton Popped While the Market Slid Today | What happened
On a gloomy day for the stock market, healthcare aesthetics specialist Soliton (NASDAQ: SOLY) was a luminous bright spot on Tuesday. The company's shares rocketed almost 12% higher, on news that its absorption into soon-to-be-parent AbbVie (NYSE: ABBV) is about to close.
So what
Soliton pointed out in a r... |
2021-12-14 00:00:00+00:00 | ABBV | Is It Too Late to Buy AbbVie Stock? | Past performance isn't a guarantee of future success, and that's as true in life as it is in the stock market. But past performance isn't meaningless either; investing in a company capable of replicating a winning strategy is a pretty good bet. With that in mind, let's look at pharma giant AbbVie (NYSE: ABBV).
Unlike m... |
2021-12-13 00:00:00+00:00 | ABBV | Noteworthy Monday Option Activity: ADBE, EXPE, ABBV | Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Adobe Inc (Symbol: ADBE), where a total of 25,946 contracts have traded so far, representing approximately 2.6 million underlying shares. That amounts to about 96.7% of ADBE's average daily trading volume over the pa... |
2021-12-13 00:00:00+00:00 | ABBV | AstraZeneca Elated On Calquence Data, IMGN's IMGN632 Appears To Be Promising In AML, XRTX On Watch | (RTTNews) - Today's Daily Dose brings you news about AstraZeneca's new long-term data related to cancer drug Calquence; superior efficacy of Novartis' Scemblix compared to Bosulif in chronic myeloid leukemia; and ImmunoGen's updated initial safety and efficacy findings from its phase 1b/2 study of IMGN632 in combinatio... |
2021-12-11 00:00:00+00:00 | ABBV | 3 Best Dividend Stocks That Wall Street Is Sleeping On | If you're an income-minded investor, you've been out of luck for a long while now. Not only have interest rates been unusually low since we recovered from the subprime crisis back in 2009, but it has also kept dividend yields similarly suppressed -- even as growth stocks have also dramatically outperformed.
That doesn'... |
2021-12-10 00:00:00+00:00 | ABBV | Drugmakers aim big price hikes at U.S. patients -congressional report | By Diane Bartz
WASHINGTON, Dec 10 (Reuters) - Drugmakers have targeted the U.S. market to earn outsized profits from old medicines, according to a report released on Friday by the House Oversight Committee that highlighted Eli Lilly and Co LLY.N, Novo Nordisk NOVOb.CO and Sanofi SASY.PA, which control the market for in... |
2021-12-10 00:00:00+00:00 | ABBV | Drugmakers aim big price hikes at U.S. patients, congressional report finds | By Diane Bartz
WASHINGTON, Dec 10 (Reuters) - Drugmakers have targeted the U.S. market to earn outsized profits from old medicines, according to a report released on Friday by the House Oversight Committee that highlighted Eli Lilly and Co LLY.N, Novo Nordisk NOVOb.CO and Sanofi SASY.PA, which dominate the market for i... |
2021-12-10 00:00:00+00:00 | ABBV | 4 Stocks That Could Be Worth $1 Trillion by 2035 | How do you know that a stock has truly made it? I would argue that reaching the $1 trillion market capitalization milestone is the telltale sign that a stock has achieved something very special. At present, there are just six such companies, but no doubt others will begin to reach those lofty heights in the years to co... |
2021-12-09 00:00:00+00:00 | ABBV | Allergan Announces Availability Of FDA-Approved Eye Drop VUITY - Quick Facts | (RTTNews) - Allergan, an AbbVie (ABBV) company, announced Thursday that VUITY (pilocarpine HCl ophthalmic solution) 1.25%, the first and only eye drop approved by the U.S. Food and Drug Administration (FDA) to treat presbyopia, is now available by prescription in pharmacies across the U.S.
The FDA approval of VUITY in ... |
2021-12-09 00:00:00+00:00 | ABBV | 5 Dividend Growth Stocks With Upside To Analyst Targets | To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years. Companies with this kind of track record tend to attract a lot of investor attention — and furthermore, "tracking" funds that follow ... |
2021-12-08 00:00:00+00:00 | ABBV | AbbVie settles New York opioid case for $200 mln as trial winds down | By Brendan Pierson
Dec 8 (Reuters) - Drugmaker AbbVie Inc ABBV.N agreed to pay $200 million to settle claims by New York that it helped fuel an epidemic of opioid addiction in the state, on the day jurors were expected to hear closing arguments at the end of a five-month trial.
New York Attorney General Letitia James a... |
2021-12-08 00:00:00+00:00 | ABBV | AbbVie Stock: Strong Dividend Growth and Reasonably Valued | AbbVie (ABBV) is an international, research-driven biopharmaceutical company specializing in developing and marketing comprehensive therapies that aim to remedy some of the world's most complicated and severe diseases.
Following AbbVie's acquisition of Allergan plc last year, the company has formed a diversified biopha... |
2021-12-08 00:00:00+00:00 | ABBV | Jury to hear final arguments in N.Y. opioid case against drugmakers | By Brendan Pierson
Dec 8 (Reuters) - Jurors in a New York state court are expected to hear closing arguments Wednesday over whether drugmakers AbbVie Inc ABBV.N and Teva Pharmaceutical Industries Ltd TEVA.TA fueled an opioid epidemic in the state, concluding a trial that has lasted more than five months.
New York's Att... |
2021-12-07 00:00:00+00:00 | ABBV | What This Label Expansion Means for Pfizer | Last month, Pfizer (NYSE: PFE) announced that the European Commission (E.C.) had authorized the company's Xeljanz immunology drug to treat adult ankylosing spondylitis -- a kind of arthritis affecting the spine and large joints -- if patients had failed at least one other therapy.
Why did the E.C. approve Xeljanz for i... |
2021-12-07 00:00:00+00:00 | ABBV | iShares Russell 1000 ETF Experiences Big Inflow | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $255.9 million dollar inflow -- that's a 0.8% increase week over week in outstanding units (from 119,900,000 to 1... |
2021-12-06 00:00:00+00:00 | ABBV | 5 Biotech Stocks To Watch In The Stock Market Today | Are These Top Biotech Stocks On Your December 2021 Watchlist?
With the start of the new trading week, investors are likely tuning in to the latest updates on the Omicron Covid variant. Accordingly, said investors could also be eyeing the top biotech stocks in thestock market todaystrong> as well. After all, the industr... |
2021-12-06 00:00:00+00:00 | ABBV | Biohaven's migraine therapy shows rapid pain relief in late-stage study | Dec 6 (Reuters) - Biohaven Pharmaceutical BHVN.N said on Monday its intranasal spray for migraine met the main goals in the drugmaker's late-stage study, showing rapid pain relief.
The study, involving 1,405 adults, demonstrated that the drug, zavegepant, was superior to placebo in relieving pain and most other "bother... |
2021-12-06 00:00:00+00:00 | ABBV | AbbVie's Upadacitinib Achieves Primary & Secondary Endpoints In Phase 3 Study On Crohn's Disease | (RTTNews) - AbbVie (ABBV) announced positive results from U-EXCEED, a Phase 3 induction study, showing upadacitinib (45 mg once daily) achieved both primary endpoints of clinical remission and endoscopic responsec at week 12.
The study showed that a significantly higher proportion of upadacitinib-treated patients achie... |
2021-12-06 00:00:00+00:00 | ABBV | AbbVie Updates RINVOQ Indications for the Treatment of RA in the U.S. | Biopharmaceutical company AbbVie (ABBV) updated the U.S. Prescribing Information and Medication Guide for RINVOQ (upadacitinib), a selective JAK inhibitor designed to treat adults with moderate to severe rheumatoid arthritis (RA).
Reason for Update
On September 1, 2021, a Drug Safety Communication (DSC) was issued b... |
2021-12-03 00:00:00+00:00 | ABBV | Noteworthy Friday Option Activity: ABBV, FCX, EXAS | Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in AbbVie Inc (Symbol: ABBV), where a total volume of 24,189 contracts has been traded thus far today, a contract volume which is representative of approximately 2.4 million underlying shares (given that e... |
2021-12-02 00:00:00+00:00 | ABBV | January 2022 Options Now Available For AbbVie (ABBV) | Investors in AbbVie Inc (Symbol: ABBV) saw new options begin trading today, for the January 2022 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new January 2022 contracts and identified one put and one call contract of particular interest.
The put cont... |
2021-12-02 00:00:00+00:00 | ABBV | AbbVie To Present At The Evercore ISI Conference; Webcast At 12:10 PM ET | (RTTNews) - AbbVie (ABBV) will participate in the 4th Annual Evercore ISI Virtual HealthCONx Conference.
The event is scheduled to begin at 12:10 PM ET on Dec. 2, 2021.
To access the live webcast, log on to https://investors.abbvie.com/events-and-presentations/upcoming-events
The views and opinions expressed herein are... |
2021-12-02 00:00:00+00:00 | ABBV | What's Next For Merck Stock After FDA Advisors Back Its Covid-19 Pill? | [Updated: Dec 1, 2021] Merck Covid-19 Pill Update
Just a few days back we discussed that the stock price of Merck (NYSE: MRK) is being weighed down due to concerns around its Covid-19 antiviral pill – Molnupiravir – which has an efficacy of 30% against hospitalization and death in high-risk patients. Yesterday, a panel... |
2021-12-01 00:00:00+00:00 | ABBV | 2 Ridiculously Cheap Dividend Stocks To Buy for 2022 | The S&P 500 had its worst day of the year on Friday, falling 900 points on the news that there could be a new obstacle in the economy's recovery: omicron, the latest COVID-19 variant.
For investors looking to get away from this volatility and find more safety, holding dividend stocks in your portfolio can be an excelle... |
2021-12-01 00:00:00+00:00 | ABBV | 3 Reasons Pfizer Stock Will Crush the Broader Market in 2022 | Pfizer (NYSE: PFE) has been the second-best-performing big pharma stock for the whole of 2021. As of the close of November, the shares were up by an astonishing 45.8% year to date, which is only slightly lower than Eli Lilly's industry-leading 47% gain in 2021.
Pfizer's shares have soared this year due to its dominance... |
2021-12-01 00:00:00+00:00 | ABBV | Is A Rise Imminent For Merck Stock After An 8% Fall In A Month? | [Updated: Nov 29, 2021] Merck Covid-19 Pill Update
The stock price of Merck (NYSE: MRK) has seen an 8% fall in a month, while it was down nearly 4% on Friday, Nov 26. This can largely be attributed to the company’s recently shared data for its Covid-19 antiviral pill – Molnupiravir – which shows lower efficacy of 30% a... |
2021-11-23 00:00:00+00:00 | ABBV | U.S. jury says CVS, other pharmacy chains helped fuel opioid epidemic | By Nate Raymond
Nov 23 (Reuters) - A federal jury on Tuesday found that pharmacy chain operators CVS Health Corp CVS.N, Walgreens Boots Alliance Inc WBA.O and Walmart Inc WMT.N helped fuel an opioid epidemic in two Ohio counties, in the first trial the companies have faced over the U.S. drug crisis.
Jurors in Cleveland... |
2021-11-23 00:00:00+00:00 | ABBV | CVS, other pharmacy chains found liable in their first trial over U.S. opioid epidemic | By Nate Raymond
Nov 23 (Reuters) - A federal jury on Tuesday found that pharmacy chain operators CVS Health Corp CVS.N, Walgreens Boots Alliance Inc WBA.O and Walmart Inc WMT.N helped fuel an opioid epidemic in two Ohio counties, in the first trial the companies have faced over the U.S. drug crisis.
Jurors in Cleveland... |
2021-11-21 00:00:00+00:00 | ABBV | Should You Buy This Blue Chip Biotech Stock? | This is arguably the most difficult time to be an income investor in decades. For one, the S&P 500 is yielding less than 1.3%, which is very close to its all-time low of 1.1% set back in 2000. Along with this, last month's annual inflation rate of 6.2% set a 31-year high. Anyone sitting on cash and waiting for a market... |
2021-11-21 00:00:00+00:00 | ABBV | 4 Top Dividend Stocks I'd Buy If I Were About to Retire | There's a different mindset for investing when you're near the point of leaving the workplace. Your focus shifts a lot more toward steady income and less to generating tremendous growth. That means dividend stocks move to the forefront.
My retirement remains years away -- in large part because I enjoy what I do too muc... |
2021-11-19 00:00:00+00:00 | ABBV | 7 Dividend Stocks to Buy for 2022 and Hold Forever | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Editor’s Note: “7 Dividend Stocks to Buy for 2022 and Hold Forever” was originally published in October 2021. It has been updated to include the latest available information.
The allure of dividend stocks should be increasing right now. The Fed has signaled... |
2021-11-18 00:00:00+00:00 | ABBV | 5 Biotech Stocks To Check Out In The Stock Market Now | 5 Top Biotech Stocks For Your November 2021 Watchlist
While investors digest the latest round of earnings and data concerning retail spending, the biotech industry remains hard at work. Accordingly, biotech stocks could also be in focus in the stock market because of this. Ever since the onslaught of the coronavirus pa... |
2021-11-18 00:00:00+00:00 | ABBV | AbbVie Brings VENCLEXTA Plus Obinutuzumab To Chronic Lymphocytic Leukemia Patients In Quebec | (RTTNews) - AbbVie (ABBV) has reached an agreement with the pan-Canadian Pharmaceutical Alliance for VENCLEXTA in combination with obinutuzumab for the treatment of adult patients with previously untreated chronic lymphocytic leukemia. Following the agreement, Quebec is the first province to reimburse the combination t... |
2021-11-18 00:00:00+00:00 | ABBV | AbbVie’s Gets EC Approval for SKYRIZI | AbbVie (ABBV) has received the European Commission’s (EC) approval for interleukin-23 (IL-23) inhibitor SKYRIZI (risankizumab) to be used separately or with methotrexate (MTX) for the treatment of active psoriatic arthritis in adults. These patients include individuals who have had an inadequate response or have been i... |
2021-11-17 00:00:00+00:00 | ABBV | AbbVie: SKYRIZI Gets EU Approval To Treat Adults With Active Psoriatic Arthritis | (RTTNews) - AbbVie (ABBV) announced that the European Union's European Commission has approved SKYRIZI (risankizumab) for the treatment of adults with active psoriatic arthritis.
Psoriatic arthritis is a systemic inflammatory disease that impacts the skin and joints, affecting approximately 30 percent of patients with ... |
2021-11-17 00:00:00+00:00 | ABBV | 1 Dividend Stock to Help You Fight Inflation | Inflation is a problem in the U.S. The Consumer Price Index, a measure of the change in prices for some common goods and services, rose by 6.2% in the 12-month period ending Oct. 31. That's well above the U.S. Federal Reserve's long-term inflation target of 2%. Inflation chips away at our purchasing power, and that's w... |
2021-11-17 00:00:00+00:00 | ABBV | Noteworthy Wednesday Option Activity: ABBV, NVAX, ADBE | Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in AbbVie Inc (Symbol: ABBV), where a total of 44,333 contracts have traded so far, representing approximately 4.4 million underlying shares. That amounts to about 77.8% of ABBV's average daily trading volume over ... |
2021-11-17 00:00:00+00:00 | ABBV | Will Investors Win With Johnson & Johnson's Planned Spinoff? Here's What History Shows | The biggest healthcare company in the world is preparing to shrink. Johnson & Johnson (NYSE: JNJ) announced last week that it plans to spin off its consumer healthcare business into a separate publicly traded entity.
J&J said that this move will unlock shareholder value and accelerate growth. But will investors really ... |
2021-11-16 00:00:00+00:00 | ABBV | Report says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion | By Ahmed Aboulenein
WASHINGTON, Nov 16 (Reuters) - Drugmakers hiked U.S. prices on seven of the 10 costliest prescription drugs in 2020 without justification, increasing drug spending by $1.67 billion, a U.S. group that reviews the value of medicines said on Tuesday.
AbbVie Inc's ABBV.N widely used Humira rheumatoid ar... |
2021-11-16 00:00:00+00:00 | ABBV | Merck Is a Dividend Play Ready to Get Back in Gear | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Before the COVID-19 pandemic, Merck (NYSE:MRK) stock was a good one to own. The performance of Merck stock matched that of the S&P 500, and it paid a steadily rising dividend.
MRK) logo outside of corporate building" width="300" height="169">
Source: Atmosp... |
2021-11-15 00:00:00+00:00 | ABBV | Buffett's Berkshire cuts U.S. drugmaker stakes, invests in drug royalty company | By Jonathan Stempel
Nov 15 (Reuters) - Warren Buffett's Berkshire Hathaway Inc BRKa.N said on Monday it eliminated its investment in Merck & Co MRK.N and reduced its stakes in AbbVie Inc ABBV.N and Bristol-Myers Squibb Co BMY.N, as it pared its overall stock market investments.
Berkshire also eliminated its small stake... |
2021-11-15 00:00:00+00:00 | ABBV | 2 High-Yield Dividend Stocks That Can Safeguard Your Portfolio Against a Market Crash | Stock market corrections are part and parcel of the investing process. As such, investors shouldn't get too worked about this inevitability. The current market, though, is starting to show ominous warning signs about a potential downturn. Valuations across the large cap space appear to be stretched in many instances, w... |
2021-11-15 00:00:00+00:00 | ABBV | 5 Long-Term Investments You'll Thank Yourself for Later | Many of us are so busy with our day-to-day lives, making short-term decisions left and right, that we don't pay much attention to the long term -- to our futures. When we do think about it, we often put off doing things that we ought to do -- like saving and investing for our retirement years. That can be a costly erro... |
2021-11-14 00:00:00+00:00 | ABBV | 4 Fantastic Dividend Stocks to Buy With Yields of 4% or More | Trade-offs can often be a necessary evil in investing. For example, you might have to take on more risk than you'd like to obtain a higher dividend payout.
However, you don't always have to make big trade-offs. Some companies have solid businesses and pay juicy dividends. Here are four fantastic dividend stocks to buy ... |
2021-11-13 00:00:00+00:00 | ABBV | Believe It or Not, These Stocks Pay You to Own Them | Most (or all) of us would love extra income, but few of us are eager to take on a second job in order to get it. Fortunately, there are other ways to get extra income -- including passive income.
Passive income is hard to beat because it requires little effort from you. Once you buy an annuity, for example, you can sit... |
2021-11-11 00:00:00+00:00 | ABBV | LABU, ALXO, ABBV, ACAD: Large Outflows Detected at ETF | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Daily S&P Biotech Bull 3X Shares (Symbol: LABU) where we have detected an approximate $95.7 million dollar outflow -- that's a 12.8% decrease week over week (from 13,711,600 to 11,961,600). ... |
2021-11-10 00:00:00+00:00 | ABBV | First Week of December 17th Options Trading For AbbVie (ABBV) | Investors in AbbVie Inc (Symbol: ABBV) saw new options become available this week, for the December 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new December 17th contracts and identified one put and one call contract of particular interest.
The... |
2021-11-09 00:00:00+00:00 | ABBV | First Week of May 2022 Options Trading For AbbVie (ABBV) | Investors in AbbVie Inc (Symbol: ABBV) saw new options begin trading this week, for the May 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 192 days until expiration the newly trading contracts represent a potential opportunity for selle... |
2021-11-08 00:00:00+00:00 | ABBV | Notable Monday Option Activity: JPM, NCLH, ABBV | Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in JPMorgan Chase & Co (Symbol: JPM), where a total volume of 45,894 contracts has been traded thus far today, a contract volume which is representative of approximately 4.6 million underlying shares (given tha... |
2021-11-08 00:00:00+00:00 | ABBV | 3 Best Biotech Stocks to Buy in November | For income investors, building a diversified portfolio of dividend stocks should be a top priority. That's because owning a wide array of stocks that span numerous industries reduces your risk profile. A payout cut for a stock that produces 1% of your total dividend income is far less painful than a cut for a stock tha... |
2021-11-08 00:00:00+00:00 | ABBV | AbbVie Presents Data from Two Phase 3 Trials on Risankizumab | AbbVie (ABBV) has presented integrated data from two Phase 3 clinical trials, KEEPsAKE 1 and KEEPsAKE 2. These studies are designed to evaluate the efficacy and safety of risankizumab (SKYRIZI) in adult patients with active psoriatic arthritis (PsA).
The data demonstrated by the biopharmaceutical company showed that 2... |
2021-11-07 00:00:00+00:00 | ABBV | Trade Alert: The Independent Director Of AbbVie Inc. (NYSE:ABBV), Roxanne Austin, Has Sold Some Shares Recently | Some AbbVie Inc. (NYSE:ABBV) shareholders may be a little concerned to see that the Independent Director, Roxanne Austin, recently sold a substantial US$8.4m worth of stock at a price of US$117 per share. That diminished their holding by a very significant 86%, which arguably implies a strong desire to reallocate capit... |
2021-11-07 00:00:00+00:00 | ABBV | Investing $100,000 in These Dividend Stocks Could Give You Nearly $6,000 in Steady Annual Income | With apologies to the rock band Dire Straits, you're not going to get "money for nothing." However, you can definitely get money on a regular basis by buying the right stocks. I'm referring, of course, to buying solid dividend stocks.
Many dividend stocks don't have high enough yields to generate significant income. Ot... |
2021-11-05 00:00:00+00:00 | ABBV | AbbVie Says Phase 3 Data On Risankizumab Shows Greater Improvements In Psoriatic Arthritis Signs | (RTTNews) - AbbVie (ABBV) said that it will present integrated data from two Phase 3 clinical trials, KEEPsAKE 1 and KEEPsAKE 2, which evaluated the efficacy and safety of risankizumab or SKYRIZI in adult patients with active psoriatic arthritis.
These results will be featured in an American College of Rheumatology Con... |
2021-11-05 00:00:00+00:00 | ABBV | What's Next For Merck Stock After An Upbeat Q3? | [Updated: Nov 3, 2021] MRK Stock Update
Merck (NYSE: MRK) recently reported its Q3 results, which were better than our estimates. The company reported sales of around $13.2 billion (up 20% y-o-y), compared to our estimate of $12.2 billion. While the Keytruda sales saw a 22% rise to $4.5 billion, Gardasil sales surged 6... |
2021-11-03 00:00:00+00:00 | ABBV | Best Stocks To Buy Today? 4 Dividend Stocks To Check Out | 4 Top Dividend Stocks In Focus For November 2021
With a booming stock market and the Federal Reserve potentially easing its economic aid, we could arguably see some volatility. Accordingly, in times of uncertainty in the market, dividend stocks would be in focus. Sure, there would be some wondering what are meme stocks... |
2021-11-03 00:00:00+00:00 | ABBV | 7 Dividend Aristocrat Stocks That Should Grace Your Portfolio | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
It’s pretty easy to continue to buy growth in this market. Third-quarter earnings for big tech companies are crushing it. The economy is climbing the wall of worry that supply chain issues are promising. So why buy dividend aristocrat stocks?
Well, first of... |
2021-11-03 00:00:00+00:00 | ABBV | 3 Explosive Biotech Stocks -- Could They Shoot Even Higher? | Investors hungry for stocks that can make big moves in a short amount of time know the biotech industry is the best place to look. A new drug approval, or simply clinical trial results that suggest success can push small-cap stocks through the roof.
Recently, Cara Therapeutics (NASDAQ: CARA), Enanta Pharmaceuticals (NA... |
2021-11-02 00:00:00+00:00 | ABBV | Why Teva Pharmaceutical Stock Is Jumping Today | What happened
Shares of Teva Pharmaceutical Industries (NYSE: TEVA) were jumping 7.1% as of 11:10 a.m. EDT on Tuesday. The solid gain came following a California court ruling yesterday in favor of Teva and three other drugmakers in opioid-related litigation filed by Orange, Los Angeles, and Santa Clara counties, and th... |
2021-11-02 00:00:00+00:00 | ABBV | Bristol Myers Squibb Just Got Some Great Regulatory News | It's no secret that Bristol Myers Squibb (NYSE: BMY) will need to innovate to grow as its three top drugs -- Revlimid, Eliquis, and Opdivo -- face patent expirations during the next decade. Fortunately, Bristol Myers Squibb got great news from a major European regulatory agency earlier this month.
The Committee for Med... |
2021-11-01 00:00:00+00:00 | ABBV | California judge rules for drugmakers in major opioid lawsuit | By Nate Raymond
Nov 1 (Reuters) - A California judge on Monday said he would rule against several large counties that accused four drugmakers of fueling an opioid epidemic, saying they had failed at trial to prove their $50 billion case.
Orange County Superior Court Judge Peter Wilson issued a tentative ruling finding ... |
2021-10-31 00:00:00+00:00 | ABBV | Best Stocks To Buy This Week? 3 Biotech Names To Know | 3 Biotech Stocks To Check Out This Week
The broader stock market appears to be taking a breather after a mostly hot week fueled by earnings. Despite all this, some would argue that biotech stocks remain relevant plays in the current market. Now the slowdown in stocks is likely due to earnings letdowns from tech names s... |
2021-10-30 00:00:00+00:00 | ABBV | FDA Approves Allergan's VUITY As First Eye Drop To Treat Presbyopia | (RTTNews) - The FDA has approved Allergan's, an AbbVie (ABBV) company, VUITY (pilocarpine HCl ophthalmic solution) 1.25% for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults.
VUITY is the first and only FDA-approved eye drop to treat this common and progressive eye condition that... |
2021-10-29 00:00:00+00:00 | ABBV | iShares Russell 1000 Growth ETF Experiences Big Inflow | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 Growth ETF (Symbol: IWF) where we have detected an approximate $118.6 million dollar inflow -- that's a 0.2% increase week over week in outstanding units (from 259,400,0... |
2021-10-29 00:00:00+00:00 | ABBV | Daily Dividend Report: ITW,HUM,AAPL,ROK,ABBV | The Board of Directors of Illinois Tool Works declared a dividend on the company's common stock of $1.22 per share for the fourth quarter of 2021. The dividend equates to $4.88 per share on a full-year basis. The dividend will be paid on January 14, 2022 to shareholders of record as of December 31, 2021.
Humana announc... |
2021-10-29 00:00:00+00:00 | ABBV | US STOCKS-Wall Street recovers from early lows on Microsoft boost | By Chuck Mikolajczak
NEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and the S&P 500 and Nasdaq inched to fresh intraday highs on Friday as gains in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.
Microsoft's shares... |
2021-10-29 00:00:00+00:00 | ABBV | AbbVie gets a shot in the arm from newer drug sales, lifts profit view | Oct 29 (Reuters) - U.S. drugmaker AbbVie Inc ABBV.N on Friday raised its 2021 adjusted profit forecast for the third time this year after a stellar performance by its newer drugs helped it beat Wall Street estimates for quarterly revenue.
The company has been focusing on gaining expanded approvals and driving growth fo... |
2021-10-29 00:00:00+00:00 | ABBV | US STOCKS-Wall Street shakes off Amazon, Apple weakness to end modestly higher | By Chuck Mikolajczak
NEW YORK, Oct 29 (Reuters) - U.S. stocks shook off early declines and closed out the last trading day of the month with modest gains as a rise in Microsoft helped offset declines in Amazon and Apple after disappointing quarterly earnings from the online retailer and iPhone maker.
Microsoft's shares... |
2021-10-29 00:00:00+00:00 | ABBV | AbbVie Breaks Above 200-Day Moving Average - Bullish for ABBV | In trading on Friday, shares of AbbVie Inc (Symbol: ABBV) crossed above their 200 day moving average of $111.26, changing hands as high as $114.47 per share. AbbVie Inc shares are currently trading up about 4.3% on the day. The chart below shows the one year performance of ABBV shares, versus its 200 day moving average... |
2021-10-29 00:00:00+00:00 | ABBV | AbbVie (ABBV) Q3 2021 Earnings Call Transcript | Image source: The Motley Fool.
AbbVie (NYSE: ABBV)
Q3 2021 Earnings Call
Oct 29, 2021, 9:00 a.m. ET
Contents:
Prepared Remarks
Questions and Answers
Call Participants
Prepared Remarks:
Operator
Thank you for standing by. Welcome to the AbbVie third quarter 2021earnings conference call [Operator instructions] I would n... |
2021-10-29 00:00:00+00:00 | ABBV | US STOCKS-Microsoft brings S&P 500, Nasdaq back into record territory | By Devik Jain and Shashank Nayar
Oct 29 (Reuters) - The S&P 500 and the Nasdaq crept back up to record territory on Friday after a boost from Microsoft, which overtook Apple Inc as the world's most valuable company after the iPhone maker posted downbeat quarterly revenue on hit from supply chain disruptions.
Wall Stree... |
2021-10-29 00:00:00+00:00 | ABBV | AbbVie Q3 21 Earnings Conference Call At 9:00 AM ET | (RTTNews) - AbbVie (ABBV) will host a conference call at 9:00 AM ET on October 29, 2021, to discuss Q3 21 earnings results.
To access the live webcast, log on to https://investors.abbvie.com/events-and-presentations/upcoming-events
The views and opinions expressed herein are the views and opinions of the author and do ... |
2021-10-29 00:00:00+00:00 | ABBV | AbbVie Q3 adjusted earnings Beat Estimates | (RTTNews) - AbbVie (ABBV) announced earnings for its third quarter that advanced from the same period last year.
The company's profit totaled $3.18 billion, or $1.78 per share. This compares with $2.31 billion, or $1.29 per share, in last year's third quarter.
Excluding items, AbbVie reported adjusted earnings of $5.95... |
2021-10-29 00:00:00+00:00 | ABBV | US STOCKS-Apple, Amazon set to knock S&P 500, Nasdaq off record peak | By Devik Jain and Shashank Nayar
Oct 29 (Reuters) - The S&P 500 and the Nasdaq indexes looked set to drop from record highs on Friday, as results from mega-cap firms Apple and Amazon.com reignited concerns of labor and supply shortages that have been at the forefront of this quarterly earnings season.
Market participan... |
2021-10-29 00:00:00+00:00 | ABBV | US STOCKS-Apple, Amazon knock S&P 500, Nasdaq off record peak; Caterpillar lifts Dow | By Devik Jain and Shashank Nayar
Oct 29 (Reuters) - The S&P 500 and the Nasdaq indexes dropped from their record highs on Friday after dismal results from mega-cap firms Apple and Amazon.com, while gains in Chevron and Caterpillar helped the blue-chip Dow outperform.
Market participants have been closely watching how c... |
2021-10-29 00:00:00+00:00 | ABBV | What To Expect From Merck's Q3? | Merck (NYSE: MRK) is scheduled to report its Q3 2021 results on Thursday, October 28. We expect the company to likely post revenue and earnings below the consensus estimates, as the spread of Covid-19 delta variant likely impacted the company’s overall vaccine sales growth, including that for Gardasil. That said, the o... |
2021-10-29 00:00:00+00:00 | ABBV | Friday Sector Leaders: Healthcare, Technology & Communications | The best performing sector as of midday Friday is the Healthcare sector, higher by 0.4%. Within that group, DexCom Inc (Symbol: DXCM) and AbbVie Inc (Symbol: ABBV) are two large stocks leading the way, showing a gain of 8.3% and 4.6%, respectively. Among healthcare ETFs, one ETF following the sector is the Health Care ... |
2021-10-29 00:00:00+00:00 | ABBV | AbbVie Raises FY21 Outlook; Boosts Dividend 8.5% - Quick Facts | (RTTNews) - While reporting financial results for the third quarter on Friday, biopharmaceutical company AbbVie Inc. (ABBV) raised its adjusted earnings guidance for the full-year 2021.
For fiscal 2021, AbbVie now projects earnings in a range of $6.29 to $6.33 per share and adjusted earnings in a range of $12.63 to $12... |
2021-10-29 00:00:00+00:00 | ABBV | AbbVie Says Cariprazine Met Primary Endpoint In Phase 3 Study For Major Depressive Disorder | (RTTNews) - Biopharmaceutical company AbbVie Inc. (ABBV) announced Friday top-line results from two Phase 3 clinical trials, Study 3111-301-001 and Study 3111-302-001, evaluating the efficacy and safety of cariprazine (Vraylar) as an adjunctive treatment for patients with major depressive disorder (MDD).
In Study 3111-... |
2021-10-29 00:00:00+00:00 | ABBV | AbbVie’s ABBV-951 Phase 3 Study Reflects Optimism; Shares Rise | Shares of AbbVie (ABBV) rose 1.2% to close at $109.67 on Thursday after the biopharmaceutical company study revealed the results of the Phase 3 study of ABBV-951, an investigational therapy.
The results showed that continuous, subcutaneous infusion of ABBV-951 met its primary endpoint. (See Insiders’ Hot Stocks on TipR... |
2021-10-28 00:00:00+00:00 | ABBV | AbbVie: Phase 3 Trial Of ABBV-951 Shows Improvement In Motor Fluctuations In Parkinson's Disease | (RTTNews) - AbbVie (ABBV) said ABBV-951 (Foslevodopa/Foscarbidopa) showed improvement in controlling motor fluctuations compared to oral Levodopa/Carbidopa medication in pivotal phase 3 trial in patients with advanced Parkinson's Disease.
The pivotal Phase 3, randomized, double-blind, double-dummy, active-controlled st... |
2021-10-28 00:00:00+00:00 | ABBV | What Investors Should Pay Attention to in AbbVie's Q3 Earnings Report | With AbbVie's (NYSE: ABBV) third-quarter earnings report scheduled for Oct. 29, shareholders and prospective investors should be on alert. AbbVie is in the middle of transitioning its revenue base away from dependence on its blockbuster drug Humira, as its exclusivity protections are starting to expire outside the U.S.... |
2021-10-28 00:00:00+00:00 | ABBV | Pre-Market Earnings Report for October 29, 2021 : XOM, CVX, ABBV, CHTR, AON, CL, LHX, PSX, LYB, WY, IMO, GWW | The following companies are expected to report earnings prior to market open on 10/29/2021. Visit our Earnings Calendar for a full list of expected earnings releases.
Exxon Mobil Corporation (XOM)is reporting for the quarter ending September 30, 2021. The oil company's consensus earnings per share forecast from the 8 ... |
2021-10-28 00:00:00+00:00 | ABBV | Should Investors Worry About AbbVie? | Pharmaceutical giant AbbVie (NYSE: ABBV) has built a good business on its long-running exclusivity of the world's top-selling drug, Humira, used for treating arthritis. However, Humira will lose its patent protection in 2023, and a handful of biosimilars -- that is, "copy cat" versions of the drug made by competitors w... |
2021-10-28 00:00:00+00:00 | ABBV | ABBV December 10th Options Begin Trading | Investors in AbbVie Inc (Symbol: ABBV) saw new options become available today, for the December 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ABBV options chain for the new December 10th contracts and identified one put and one call contract of particular interest.
The put... |
2021-10-27 00:00:00+00:00 | ABBV | AbbVie Takes Another Step Toward Its Post-Humira Future | Since AbbVie (NYSE: ABBV) began trading in December 2012, it has left the S&P 500 in the dust. AbbVie has outperformed the S&P 500 by nearly 60% in the past nine years. Most of the returns that AbbVie has generated for its shareholders have come from its top-selling drug in the world, Humira, which has grown sales from... |
2021-10-27 00:00:00+00:00 | ABBV | 3 Stocks You Can Still Buy on Sale in a Ridiculously Expensive Market | Most stocks are priced at a premium right now. Wall Street knows it. I know it. You know it. In fact, the Shiller cyclically adjusted price-to-earnings (CAPE) ratio is at its highest level since early 2000 during the heady dot-com days.
But that doesn't mean that every stock is trading at a nosebleed level. Here are th... |
2021-10-26 00:00:00+00:00 | ABBV | Was Atea Pharmaceutical's Flop Predictable? | This month, as Merck (NYSE: MRK) moves forward with an Emergency Use Authorization in the U.S. for its oral antiviral for COVID-19, Atea Pharmaceuticals (NASDAQ: AVIR) stock saw a significant drop. Unfortunately, investors are unlikely to see the small-cap biotech replicate Moderna's success as the next COVID-19 underd... |
2021-10-25 00:00:00+00:00 | ABBV | Bausch, Clearside receive U.S. approval for eye injection | Oct 25 (Reuters) - Bausch Health Companies Inc BHC.TO and Clearside Biomedical Inc CLSD.O said on Monday they received approval from the U.S. health regulator for their eye injection, giving patients access to a novel treatment for vision loss resulting from an inflammatory eye condition.
The drug, Xipere, is injected ... |
2021-10-25 00:00:00+00:00 | ABBV | What Could These Clinical Results Mean for AbbVie's Shareholders? | Earlier this month, AbbVie (NYSE: ABBV) announced promising top-line results from a phase 3 study examining the efficacy and safety of Rinvoq in treating patients diagnosed with active ankylosing spondylitis. But what impact could these clinical results have on pharma stock AbbVie in the years ahead?
Let's dive into th... |
2021-10-21 00:00:00+00:00 | ABBV | Progenity Has Seven Quarters Left to Reverse Its Burn Rate | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Progenity (NASDAQ:PROG) is a San Diego-based biotech company that specializes in gastrointestinal health and oral biotherapeutics. Right now the company has no real revenue to speak of and is burning through cash. If Progenity can cut its burn rate, PROG st... |
2021-10-21 00:00:00+00:00 | ABBV | Top Dividend Stocks To Buy In 2021? 3 In Focus | 3 Dividend Stocks Worth Checking Out Right Now
With all the focus on earnings and an improving job market, thestock market todayis filled with upbeat news. Regardless, some would argue that investors should not overlook dividend stocks as well. For the most part, this would be due to rising concerns over inflation as t... |
2021-10-21 00:00:00+00:00 | ABBV | HDV, ABBV, BMY, TFC: ETF Outflow Alert | Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core High Dividend ETF (Symbol: HDV) where we have detected an approximate $93.1 million dollar outflow -- that's a 1.2% decrease week over week (from 76,500,000 to 75,550,000). Amon... |
2021-10-21 00:00:00+00:00 | ABBV | Could This Be the Next Blockbuster Indication for Eli Lilly? | Eli Lilly (NYSE: LLY) and Incyte's (NASDAQ: INCY) drug, Olumiant, has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) to treat hospitalized COVID-19 patients with or without remdesivir. While the EUAs for Olumiant to be used as both a monotherapy or a combination therapy with... |
2021-10-20 00:00:00+00:00 | ABBV | Could This Beaten-Down Biotech Stock Be the Next Buyout Target? | What do AbbVie, Bristol Myers Squibb, and AstraZeneca all have in common? All three are among the largest pharma companies in the world. But all of these drugmakers have also closed high-profile acquisitions within the past two years. These deals helped them bolster their lineups and deepen their pipelines, among other... |
2021-10-19 00:00:00+00:00 | ABBV | FDA OKs Cyltezo As First Interchangeable Biosimilar To Humira | (RTTNews) - The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses.
Cylt... |
2021-10-19 00:00:00+00:00 | ABBV | 3 Leading Healthcare Stocks to Buy in 2021 and Beyond | Resmed (NYSE: RMD), Walgreens Boots Alliance (NASDAQ: WBA) and AbbVie (NYSE: ABBV) are profitable companies that have clear paths to future revenue growth.
ResMed is already an industry leader in sleep apnea therapies, an area that's expected to grow as our population ages. Walgreens Boots Alliance is jumping onto the ... |
2021-10-18 00:00:00+00:00 | ABBV | 2 Best Biotech Stocks to Buy Right Now | It's no secret that it has progressively become more difficult for investors to find high-yield investments these days. After all, the current 1.3% yield of the S&P 500 isn't that far off the 1.1% yield of the index leading up to the dot-com bubble that occurred two decades ago.
Frothy market valuations can lead income... |
2021-10-18 00:00:00+00:00 | ABBV | Why Revance Therapeutics Stock Is Getting Crushed Today | What happened
Shares of the aesthetic and therapeutic company Revance Therapeutics (NASDAQ: RVNC) are in for a turbulent Monday. In premarket trading, the biopharma's shares sank by as much as 34% on heavy volume.
What's sparking this double-digit sell-off? After the closing bell last Friday, Revance announced that the... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.